Literature DB >> 30571398

Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source.

George Ntaios1, Gregory Y H Lip2,3,4, Dimitris Lambrou1, Patrik Michel5, Kalliopi Perlepe1,5, Ashraf Eskandari5, Stefania Nannoni5, Gaia Sirimarco5, Davide Strambo5, Konstantinos Vemmos6, Eleni Koroboki7,8, Efstathios Manios9, Anastasia Vemmou1, Ana Rodríguez-Campello10, Elisa Cuadrado-Godia10, Jaume Roquer10, Valentina Arnao11, Valeria Caso11, Maurizio Paciaroni11, Exuperio Diez-Tejedor12, Blanca Fuentes12, Jorge Rodríguez Pardo12, Antonio Arauz13, Sebastian F Ameriso14, Lucía Pertierra14, Maia Gómez-Schneider14, Maximiliano A Hawkes15, Fabio Bandini, Beatriz Chavarria Cano16,17, Ana Maria Iglesias Mohedano16,17, Andrés García Pastor16, Antonio Gil-Núñez16,17, Jukka Putaala18, Turgut Tatlisumak18,19,20, Miguel A Barboza21, Efstathia Karagkiozi1, Konstantinos Makaritsis, Vasileios Papavasileiou1,22.   

Abstract

Background and Purpose- We aimed to assess if renal function can aid in risk stratification for ischemic stroke or transient ischemic attack (TIA) recurrence and death in patients with embolic stroke of undetermined source (ESUS). Methods- We pooled 12 ESUS datasets from Europe and America. Renal function was evaluated using the estimated glomerular filtration rate (eGFR) and analyzed in continuous, binary, and categorical way. Cox-regression analyses assessed if renal function was independently associated with the risk for ischemic stroke/TIA recurrence and death. The Kaplan-Meier product limit method estimated the cumulative probability of ischemic stroke/TIA recurrence and death. Results- In 1530 patients with ESUS followed for 3260 patient-years, there were 237 recurrences (15.9%) and 201 deaths (13.4%), corresponding to 7.3 ischemic stroke/TIA recurrences and 5.6 deaths per 100 patient-years, respectively. Renal function was not associated with the risk for ischemic stroke/TIA recurrence when forced into the final multivariate model, regardless if it was analyzed as continuous (hazard ratio, 1.00; 95% CI, 0.99-1.00 for every 1 mL/min), binary (hazard ratio, 1.27; 95% CI, 0.87-1.73) or categorical covariate (likelihood-ratio test 2.59, P=0.63 for stroke recurrence). The probability of ischemic stroke/TIA recurrence across stages of renal function was 11.9% for eGFR ≥90, 16.6% for eGFR 60-89, 21.7% for eGFR 45-59, 19.2% for eGFR 30-44, and 24.9% for eGFR <30 (likelihood-ratio test 2.59, P=0.63). The results were similar for the outcome of death. Conclusions- The present study is the largest pooled individual patient-level ESUS dataset, and does not provide evidence that renal function can be used to stratify the risk of ischemic stroke/TIA recurrence or death in patients with ESUS.

Entities:  

Keywords:  brain ischemia; glomerular filtration rate; probability; recurrence; stroke

Mesh:

Year:  2018        PMID: 30571398     DOI: 10.1161/STROKEAHA.118.023281

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.

Authors:  Victor J Del Brutto; Han-Christoph Diener; J Donald Easton; Christopher B Granger; Lisa Cronin; Eva Kleine; Claudia Grauer; Martina Brueckmann; Kazunori Toyoda; Peter D Schellinger; Philippe Lyrer; Carlos A Molina; Aurauma Chutinet; Christopher F Bladin; Conrado J Estol; Ralph L Sacco
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

Review 2.  Interactions Between Kidney Function and Cerebrovascular Disease: Vessel Pathology That Fires Together Wires Together.

Authors:  Sandro Marini; Marios K Georgakis; Christopher D Anderson
Journal:  Front Neurol       Date:  2021-11-24       Impact factor: 4.003

3.  Etiology and Outcome of Ischemic Stroke in Patients With Renal Impairment Including Chronic Kidney Disease: Japan Stroke Data Bank.

Authors:  Kaori Miwa; Masatoshi Koga; Michikazu Nakai; Sohei Yoshimura; Yusuke Sasahara; Junpei Koge; Kazutaka Sonoda; Akiko Ishigami; Yoshitaka Iwanaga; Yoshihiro Miyamoto; Shotai Kobayashi; Kazuo Minematsu; Kazunori Toyoda
Journal:  Neurology       Date:  2022-03-08       Impact factor: 11.800

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.